495 Shares in CVS Health Co. (NYSE:CVS) Bought by Livelsberger Financial Advisory

Livelsberger Financial Advisory acquired a new position in shares of CVS Health Co. (NYSE:CVS) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 495 shares of the pharmacy operator’s stock, valued at approximately $31,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Steph & Co. lifted its stake in shares of CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 288 shares during the period. Crewe Advisors LLC bought a new position in shares of CVS Health in the first quarter valued at approximately $40,000. Retirement Group LLC lifted its stake in CVS Health by 54.3% in the first quarter. Retirement Group LLC now owns 517 shares of the pharmacy operator’s stock valued at $41,000 after purchasing an additional 182 shares during the last quarter. Kathleen S. Wright Associates Inc. purchased a new position in CVS Health in the third quarter valued at approximately $33,000. Finally, First Community Trust NA lifted its position in shares of CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after acquiring an additional 302 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Down 3.5 %

Shares of CVS stock traded down $2.09 during trading hours on Monday, hitting $58.25. 8,623,362 shares of the company’s stock traded hands, compared to its average volume of 11,215,543. The stock’s fifty day simple moving average is $59.80 and its two-hundred day simple moving average is $60.43. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The stock has a market cap of $73.13 billion, a price-to-earnings ratio of 10.60, a PEG ratio of 0.93 and a beta of 0.54. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. The company had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The firm’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter last year, the firm earned $2.21 earnings per share. On average, analysts expect that CVS Health Co. will post 6.51 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.57%. The ex-dividend date is Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Evercore ISI increased their target price on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft reduced their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a research note on Tuesday, October 1st. Royal Bank of Canada reissued an “outperform” rating and issued a $68.00 target price on shares of CVS Health in a research note on Wednesday, September 4th. Finally, TD Cowen raised CVS Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $59.00 to $85.00 in a research note on Friday, October 4th. Nine research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $75.26.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.